Business
Board Appointment and Acquisition
Board Appointment and Acquisition.
About this update from Craneware Plc
[{"type":"text","content":"\n \nRNS Number : 1793Q Craneware plc 28 August 2014 \n\n Craneware plc\n(\"Craneware\", \"the Group\" or the \"Company\")\n \nAppointment of Non-executive Director\nand Acquisition\n \nCraneware increases breadth of Healthcare experience and product portfolio through appointment of new Non-executive Director and acquisition of Kestros Limited\n \n \n28 August 2014 - Craneware (AIM: CRW.L), the market leader in automated revenue integrity solutions for the US healthcare market, is pleased to announce the appointment of Russ Rudish to the Board as Non-executive Director, and the acquisition of Kestros Limited (\"Kestros\").\n \nNon-executive Director Appointment\n \nRuss Rudish has more than 30 years' experience in serving the Healthcare industry, both in the United States and internationally. His most recent role was Global Sector Leader for Healthcare at Deloitte Touche Tohmatsu, where he led the $2 billion global consulting, audit, tax and financial advisory business, developing the firm's Global health care strategy. He joined Deloitte in 2006 from Eclipsys Corp., which was acquired by Allscripts in 2010. Russ joins the Craneware board with immediate effect. He is an active speaker and contributor to thought leadership on today's most pressing Healthcare business issues.\n \nAcquisition of Kestros Limited\n \nAs part of its commitment to expanding the use of innovative technology in Healthcare, Craneware has acquired the assets and intellectual property of an emerging Scottish technology company, Kestros Limited for a maximum consideration of £1.25 million. The acquisition will provide Craneware with a technology platform in the high growth Patient Access market, addressing the growing level of consumerisation within Healthcare.\n \nKestros has established early market entry into the growing area of mobile technology and patient connectivity within the Healthcare industry. Through the acquisition, Craneware will provide the funding for further development of the technology from its current use in a select number of NHS Trusts to broader use in the Healthcare market, integrating with Craneware's existing Medical Necessity technology within its Patient Access product family. \n \nCraneware will acquire Kestros and all related assets for a maximum of £1,250,000 which w...